Category Specific RSS

News

Auditors slam Sky and Space, possibly the most hated company listed on the ASX

Having been in a voluntary trading halt since last trading on 3 April 2019, shareholders of Sky and Space Global (ASX: SAS) may finally have some closure with signs now pointing to the Israeli-based space company being put into administration. 

Earlier in the year, we brought attention to the series of capital raises undertaken by Sky and Space, of which funds raised failed to deliver shareholders any returns. 

But with the Company having again proposed a capital raising exercise to continue its operations, Sky and Space finally received an Interim Stop Order from the Australian Securities and Investments Commission (ASIC), halting the proposed $15.8m capital raise in its tracks.

Of concern from regulatory body was the Company’s omission of audited accounts which would have highlighted a dire financial situation. 

The Company today released their 2019 Annual Report where the Auditor’s Independent Report raised serious concerns into Sky and Space’s operations – something shareholders have been voicing since before the series of voluntary trading halts commenced. 

Also identified within the Annual Report was the $1.65 million paid to Directors in salary and consulting fees, including $527,710 to CEO and Managing Director, Meir Moalem. 

This however was a significant saving for the Company which had previously spent $8.4m on Key Personnel Remuneration in FY18. 

For the year ending 30 June 2019, Sky and Space Global reported revenues totaling $0.00 for a total loss of $30,395,707. 

They did however have $1.93m of cash in bank.

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago